Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Howard

Showing results (591-600 of 876) with videos related to

Pageof 88
Sort By:
Cancer Research|January 1, 2016
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of CancerJill A Ohar, Mitchell Cheung, Jacqueline Talarchek, et al.
JAMA Network Open|June 3, 2021
Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs CohortKristina Vaculik, Michael Luu, Lauren E Howard, et al.
BJU International|September 4, 2019
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trialEmma H Allott, Ilona Csizmadi, Lauren E Howard, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 3, 2015
Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital databasePrabhakar Mithal, Lauren E Howard, William J Aronson, et al.
Thrombosis and Haemostasis|December 8, 2007
A nonstop mutation in the factor (F)X gene of a severely haemorrhagic patient with complete absence of coagulation FXAfshin Ameri, Deepa K Machiah, Thuy T Tran, et al.
Journal of Neurochemistry|February 4, 1999
Dopamine D2-receptor isoforms expressed in AtT20 cells inhibit Q-type high-voltage-activated Ca2+ channels via a membrane-delimited pathwayS E Wolfe, D E Howard, J A Schetz, et al.
Scientific Reports|October 15, 2016
The bornavirus-derived human protein EBLN1 promotes efficient cell cycle transit, microtubule organisation and genome stabilityKatie N Myers, Giancarlo Barone, Anil Ganesh, et al.
Contemporary Clinical Trials|March 30, 2019
Proactive text messaging (GetReady2Quit) and nicotine replacement therapy to promote smoking cessation among smokers in primary care: A pilot randomized trial protocolG R Kruse, E Park, J E Haberer, et al.
Urologic Oncology|January 2, 2019
Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH databaseMary M Everist, Lauren E Howard, William J Aronson, et al.
Urologic Oncology|February 13, 2018
First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH databaseMichelle L McDonald, Lauren E Howard, William J Aronson, et al.
Pageof 88

Showing results (591-600 of 876) with videos related to

Sort By:
Pageof 88
Cancer Research|January 1, 2016
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of CancerJill A Ohar, Mitchell Cheung, Jacqueline Talarchek, et al.
JAMA Network Open|June 3, 2021
Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs CohortKristina Vaculik, Michael Luu, Lauren E Howard, et al.
BJU International|September 4, 2019
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trialEmma H Allott, Ilona Csizmadi, Lauren E Howard, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 3, 2015
Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital databasePrabhakar Mithal, Lauren E Howard, William J Aronson, et al.
Thrombosis and Haemostasis|December 8, 2007
A nonstop mutation in the factor (F)X gene of a severely haemorrhagic patient with complete absence of coagulation FXAfshin Ameri, Deepa K Machiah, Thuy T Tran, et al.
Journal of Neurochemistry|February 4, 1999
Dopamine D2-receptor isoforms expressed in AtT20 cells inhibit Q-type high-voltage-activated Ca2+ channels via a membrane-delimited pathwayS E Wolfe, D E Howard, J A Schetz, et al.
Scientific Reports|October 15, 2016
The bornavirus-derived human protein EBLN1 promotes efficient cell cycle transit, microtubule organisation and genome stabilityKatie N Myers, Giancarlo Barone, Anil Ganesh, et al.
Contemporary Clinical Trials|March 30, 2019
Proactive text messaging (GetReady2Quit) and nicotine replacement therapy to promote smoking cessation among smokers in primary care: A pilot randomized trial protocolG R Kruse, E Park, J E Haberer, et al.
Urologic Oncology|January 2, 2019
Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH databaseMary M Everist, Lauren E Howard, William J Aronson, et al.
Urologic Oncology|February 13, 2018
First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH databaseMichelle L McDonald, Lauren E Howard, William J Aronson, et al.
Pageof 88